Search research articles
Contact Us
Filters
Showing results (171-180 of 215) with videos related to
Page
of 22
Sort By:
Blood Advances
|
February 24, 2026
Exposure to Agent Orange and Association with Myelodysplastic Syndromes
Mikkael A Sekeres, Amy E DeZern, Michael Otterstatter, et al.
Blood
|
January 18, 2011
Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias
Judith E Karp, B Douglas Smith, Linda S Resar, et al.
Leukemia Research
|
September 5, 2017
Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature
Kelly J Norsworthy, Amy E DeZern, Hua-Ling Tsai, et al.
Cancer Research
|
June 17, 2006
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms
Steven D Gore, Stephen Baylin, Elizabeth Sugar, et al.
Transfusion
|
November 24, 2016
Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States
Alexander B Pine, Eun-Ju Lee, Mikkael Sekeres, et al.
Leukemia Research
|
September 26, 2021
Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia
Hetty E Carraway, Yazeed Sawalha, Ivana Gojo, et al.
Blood Neoplasia
|
June 2, 2025
Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study
Amy E DeZern, Johannes B Goll, Travis L Jensen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 15, 2011
NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes
Peter L Greenberg, Eyal Attar, John M Bennett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 13, 2006
Myelodysplastic syndromes clinical practice guidelines in oncology
Peter L Greenberg, Maria R Baer, John M Bennett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2012
Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias
Judith E Karp, Brian M Thomas, Jacqueline M Greer, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 215) with videos related to
Sort By:
Page
of 22
Blood Advances
|
February 24, 2026
Exposure to Agent Orange and Association with Myelodysplastic Syndromes
Mikkael A Sekeres, Amy E DeZern, Michael Otterstatter, et al.
Blood
|
January 18, 2011
Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias
Judith E Karp, B Douglas Smith, Linda S Resar, et al.
Leukemia Research
|
September 5, 2017
Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature
Kelly J Norsworthy, Amy E DeZern, Hua-Ling Tsai, et al.
Cancer Research
|
June 17, 2006
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms
Steven D Gore, Stephen Baylin, Elizabeth Sugar, et al.
Transfusion
|
November 24, 2016
Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States
Alexander B Pine, Eun-Ju Lee, Mikkael Sekeres, et al.
Leukemia Research
|
September 26, 2021
Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia
Hetty E Carraway, Yazeed Sawalha, Ivana Gojo, et al.
Blood Neoplasia
|
June 2, 2025
Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study
Amy E DeZern, Johannes B Goll, Travis L Jensen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 15, 2011
NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes
Peter L Greenberg, Eyal Attar, John M Bennett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 13, 2006
Myelodysplastic syndromes clinical practice guidelines in oncology
Peter L Greenberg, Maria R Baer, John M Bennett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2012
Phase I and pharmacologic trial of cytosine arabinoside with the selective checkpoint 1 inhibitor Sch 900776 in refractory acute leukemias
Judith E Karp, Brian M Thomas, Jacqueline M Greer, et al.
Page
of 22